We are live on ! Find out more
TFFP

TFF Pharmaceuticals, Inc. Common Stock
TFFP

Delisted

TFFP was delisted on the 12th of December, 2024.

Back to rankings

4 hedge funds and large institutions have $196 invested in TFF Pharmaceuticals, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less funds holding

Funds holding: 23 → 4 (-19)

95% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 20

100% less capital invested

Capital invested by funds: $1.48M → $196 (-$1.47M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
4
Holders Change
-19
Holders Change %
-82.61%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CC
Carlson Capital
Texas
-$590K
2
AC
Armistice Capital
New York
-$458K
3
WIM
Westside Investment Management
California
-$151K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$56.3K
5
Renaissance Technologies
Renaissance Technologies
New York
-$41.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
1
SBI Securities
Japan
$196 +$4.19K +3,010 New
CC
2
Carlson Capital
Texas
– -$590K -293,460 Closed
AC
3
Armistice Capital
New York
– -$458K -228,000 Closed
WIM
4
Westside Investment Management
California
– -$151K -75,264 Closed
Geode Capital Management
5
Geode Capital Management
Massachusetts
– -$56.3K -27,999 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
– -$41.2K -20,497 Closed
Citadel Advisors
7
Citadel Advisors
Florida
– -$27.3K -13,579 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$24.4K -12,136 Closed
NL
9
NWAM LLC
Washington
– -$20.6K -10,240 Closed
BlackRock
10
BlackRock
New York
– -$14.4K -7,186 Closed
TRCT
11
Tower Research Capital (TRC)
New York
– -$3.92K -1,948 Closed
NA
12
Nordwand Advisors
Pennsylvania
– -$2.01K -1,000 Closed
UOTTAIMCU
13
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
– -$1.77K -882 Closed
UBS Group
14
UBS Group
Switzerland
– -$1.36K -675 Closed
RCM
15
Raleigh Capital Management
North Carolina
– -$183 -91 Closed
Wells Fargo
16
Wells Fargo
California
– -$123 -61 Closed
HPC
17
HM Payson & Co
Maine
– -$121 -60 Closed
Osaic Holdings
18
Osaic Holdings
Arizona
– -$80 -40 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$64 -32 Closed
Bank of America
20
Bank of America
North Carolina
– -$56 -28 Closed
DB
21
Danske Bank
Denmark
– -$2 -1 Closed

TFFP Hedge Fund Activity: Q4 2024 in Review

4 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q4 2024, worth a combined $196 — down 100% from $1.48M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of TFFP and 1 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Carlson Capital, exiting entirely with an estimated $590K sold.

  • 4 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q4 2024, down from 23 in Q3 2024.
  • Funds reported $196 of TFF Pharmaceuticals, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 1 fund opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q4 2024 and 20 closed out, a net change of -19 holders.
  • The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q4 2024 was Carlson Capital, an estimated $590K sold.

Based on aggregated 13F filings for Q4 2024.